Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ewenstein

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
FEIBA safety profile in multiple modes of clinical and home-therapy applicationH Luu, B Ewenstein
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 30, 2014
The burden of bleeding in haemophilia: is one bleed too many?A Gringeri, B Ewenstein, A Reininger
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 29, 2015
The role of previously untreated patient studies in understanding the development of FVIII inhibitorsM Carcao, W Re, B Ewenstein
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2004
Central venous access devices in haemophiliaL A Valentino, B Ewenstein, R J Navickis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2016
Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(®) in prophylactic therapyK Varadi, S Tangada, M Loeschberger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2011
Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trialsK Fischer, P Collins, S Björkman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 29, 2010
Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practiceJ Oldenburg, J Goudemand, L Valentino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 6, 2013
Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitorsS V Antunes, S Tangada, O Stasyshyn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 19, 2009
Emerging clinical concerns in the ageing haemophilia patientB A Konkle, C Kessler, L Aledort, et al.
Journal of Thrombosis and Haemostasis : JTH|January 16, 2009
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia AP W Collins, V S Blanchette, K Fischer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
FEIBA safety profile in multiple modes of clinical and home-therapy applicationH Luu, B Ewenstein
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 30, 2014
The burden of bleeding in haemophilia: is one bleed too many?A Gringeri, B Ewenstein, A Reininger
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 29, 2015
The role of previously untreated patient studies in understanding the development of FVIII inhibitorsM Carcao, W Re, B Ewenstein
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2004
Central venous access devices in haemophiliaL A Valentino, B Ewenstein, R J Navickis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2016
Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(®) in prophylactic therapyK Varadi, S Tangada, M Loeschberger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2011
Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trialsK Fischer, P Collins, S Björkman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 29, 2010
Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practiceJ Oldenburg, J Goudemand, L Valentino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 6, 2013
Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitorsS V Antunes, S Tangada, O Stasyshyn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 19, 2009
Emerging clinical concerns in the ageing haemophilia patientB A Konkle, C Kessler, L Aledort, et al.
Journal of Thrombosis and Haemostasis : JTH|January 16, 2009
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia AP W Collins, V S Blanchette, K Fischer, et al.
Pageof 2